Protagonist Therapeutics (PTGX) Amortizatization of Intangibles (2017 - 2025)

Protagonist Therapeutics (PTGX) has disclosed Amortizatization of Intangibles for 9 consecutive years, with $1.3 million as the latest value for Q4 2025.

  • Quarterly Amortizatization of Intangibles fell 51.59% to $1.3 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $7.2 million through Dec 2025, down 18.61% year-over-year, with the annual reading at $7.2 million for FY2025, 18.61% down from the prior year.
  • Amortizatization of Intangibles hit $1.3 million in Q4 2025 for Protagonist Therapeutics, down from $1.7 million in the prior quarter.
  • In the past five years, Amortizatization of Intangibles ranged from a high of $2.8 million in Q3 2024 to a low of -$1.5 million in Q3 2022.
  • Historically, Amortizatization of Intangibles has averaged $1.2 million across 5 years, with a median of $1.2 million in 2021.
  • Biggest five-year swings in Amortizatization of Intangibles: crashed 412.22% in 2022 and later skyrocketed 2010.34% in 2024.
  • Year by year, Amortizatization of Intangibles stood at $584000.0 in 2021, then skyrocketed by 56.51% to $914000.0 in 2022, then soared by 208.32% to $2.8 million in 2023, then fell by 2.06% to $2.8 million in 2024, then crashed by 51.59% to $1.3 million in 2025.
  • Business Quant data shows Amortizatization of Intangibles for PTGX at $1.3 million in Q4 2025, $1.7 million in Q3 2025, and $1.9 million in Q2 2025.